首页|四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析

四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析

扫码查看
目的 探讨四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌(Hp)感染患者的临床效果.方法 选择某院于2020年1月10日—11月14日收治的消化性溃疡合并幽门螺杆菌感染患者100例进行前瞻性研究,随机分为研究组50例与对照组50例.对照组患者采用四联疗法治疗,研究组患者在对照组基础上结合康复新液治疗.2组疗程均为2周.比较2组治疗疗效和Hp根除率,治疗前后主要症状和炎症因子变化.结果 研究组的总有效率为 90.00%,Hp 根除率为 96.00%,高于对照组的 72.00%和 76.00%(x2=5.263、8.306,P=0.022、0.004).治疗后,研究组嗳气反酸、腹胀和腹痛积分低于对照组,差异有统计学意义(t=13.614、11.434、19.219,P<0.001);且2组嗳气反酸、腹胀和腹痛积分均低于治疗前,差异有统计学意义(t研究组=26.531、28.590、31.312,t对照组=11.638、15.840、20.645,P均<0.05).治疗后,研究组IL-2高于对照组,IL-6、IL-8、IL-17低于对照组,差异有统计学意义(t=9.585、8.355、8.188、14.906,P均<0.001);且2组IL-2均高于治疗前,IL-6、IL-8、IL-17均低于治疗前,差异有统计学意义(t研究组=19.309、14.326、13.150、23.537,t对照组=6.444、5.477、6.636、8.026,P均<0.05).结论 四联疗法联合康复新液对消化性溃疡合并Hp感染患者疗效良好,且可减轻炎症反应.
Clinical effect analysis of combination of quadruple therapy and Kang-fuxin solution on patients with peptic ulcer complicated with Helicobacter pylori(Hp)infection
Objective To study the clinical effect of the combination of quadruple therapy and Kangfuxin solution on patients with peptic ulcer complicated by Helicobacter pylori(Hp)infection.Methods A total of 100 patients with pep-tic ulcer complicated with Hp infection admitted to a hospital from January 10,2020,to November 14,2020,were selected for a prospective study,and they were randomly divided into a study group(50 cases)and a control group(50 cases).The patients in the control group were treated with quadruple therapy,and the patients in the study group were treated with Kang-fuxin solution based on the control group.The course of treatment in both groups was 2 weeks.The treatment efficacy,Hp eradication rate,main symptoms,and inflammatory factors before and after treatment were compared between the two groups.Results The total effective rate and Hp eradication rate of the study group were 90.00%and 96.00%,which were higher than those of the control group(72.00%and 76.00%)respectively(x2=5.263,8.306,P=0.022,0.004).After treatment,the scores of belching acid reflux,abdominal distension,and abdominal pain in the study group were lower than those in the con-trol group,and the differences were statistically significant(t=13.614,11.434.19.219,all P<0.001),and also the scores of belching acid reflux,abdominal distension,and abdominal pain in the two groups were lower than those before treatment,and the differences were statistically significant(tstudy group=26.531,28.590,31.312,tcontrol group=11.638,15.840,20.645,all P<0.05).After treatment,the IL-2 in the study group was higher than that in the control group,and the IL-6,IL-8,and IL-17 were lower than those in the control group,and the differences were statistically significant(t=9.585,8.355,8.188,14.906,all P<0.001).The IL-2 in the two groups was higher than that before treatment,and the IL-6,IL-8,and IL-17 were lower than those before treatment,and the differences were statistical-ly significant(tstudy group=19.309,14.326,13.150,23.537,tcontrol group=6.444,5.477,6.636,8.026,all P<0.05).Conclu-sion Quadruple therapy combined with Kangfuxin solu-tion has good efficacy in patients with peptic ulcer and Hp infection and can reduce inflammatory response.

Quadruple therapyKangfuxin solutionPeptic ulcerHelicobacter pylori(Hp)infection

孙敏

展开 >

濮阳市安阳地区医院药学部,河南濮阳 455000

四联疗法 康复新液 消化性溃疡 幽门螺杆菌感染

2024

中国校医
江苏省预防医学会 中华预防医学会

中国校医

影响因子:0.378
ISSN:1001-7062
年,卷(期):2024.38(1)
  • 20